Modulation of TGF-β signaling new approaches toward kidney disease and fibrosis therapy
Top Cited Papers
Open Access
- 3 February 2025
- journal article
- review article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 21 (4) , 1649-1665
Abstract
The prevalence of chronic kidney disease (CKD) is increasing worldwide, posing a significant healthcare challenge. Despite the immense burden of CKD, optimal therapies remain limited in impact. Kidney fibrosis is a common mediator of all CKD progression, characterized by excessive extracellular matrix deposition and scarring of kidney parenchyma. Transforming growth factor-β (TGF-β) is a potent pro-fibrotic cytokine that signals through canonical and non-canonical pathways to promote kidney cell damage and fibrosis progression, thus garnering much interest as an optimal therapeutic target for CKD. However, the clinical translation of TGF-β inhibition in CKD and other disease settings has faced substantial challenges, particularly due to the highly pleiotropic effects of TGF-β in organ homeostasis and disease. Here, we review the kidney cell-specific biological effects of TGF-β signaling, discuss the current challenges in therapeutic targeting TGF-β in CKD, and provide the rationale for alternative targeting strategies of TGF-β signaling as potential approaches in CKD therapy. Selective inhibition of TGF-β signaling modulators to fine-tune TGF-β inhibition without a broad blockade may lead to new and safer treatments for CKD.Keywords
This publication has 240 references indexed in Scilit:
- Expression of cytokines and growth factors in human glomerulonephritidesPediatric Nephrology, 1993
- Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.Proceedings of the National Academy of Sciences, 1993
- Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys.1993
- Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.Proceedings of the National Academy of Sciences, 1993
- Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney diseaseNature, 1992
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992
- Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cellsKidney International, 1992
- Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1Nature, 1990
- Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex.Molecular and Cellular Biology, 1990
- Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells.Journal of Biological Chemistry, 1988